Kerala Ayurveda Limited
BSE: KERALAYUR
Prev Close
469.15
Open Price
475
Volume
10,905
Today Low / High
457.65 / 476
52 WK Low / High
305 / 625
Range
439 - 485
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 462.15, reflecting a change of -7 (-1.49206%). The expected target range on the BSE is 439 - 485. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Kerala Ayurveda Limited Graph
Kerala Ayurveda Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Kerala Ayurveda Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 462.15, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 462.15 | 466.77 | 420.09 - 513.45 |
| 471.39 | 377.11 - 565.67 | ||
| 476.01 | 333.21 - 618.82 | ||
| Bearish Scenario | 462.15 | 457.53 | 411.78 - 503.28 |
| 452.91 | 362.33 - 543.49 | ||
| 448.29 | 313.80 - 582.77 |
Overview of Kerala Ayurveda Limited
ISIN
INE817B01025
Industry
Medical - Pharmaceuticals
Vol.Avg
27,372
Market Cap
5,560,797,230
Last Dividend
0
Official Website
IPO Date
DCF Diff
579.65
DCF
-117
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 120.33 Cr | 81.94 Cr | 38.39 Cr | 0.3191 | 0.00 Cr | 14.29 Cr | -9.97 Cr | -14.70 Cr | -12.56 | -3.17 Cr | -0.1222 |
| 2024-03-31 | 102.34 Cr | 57.57 Cr | 44.77 Cr | 0.4375 | 0.76 Cr | 7.06 Cr | 4.80 Cr | -1.53 Cr | -1.38 | 7.08 Cr | -0.0149 |
| 2023-03-31 | 93.05 Cr | 20.05 Cr | 34.73 Cr | 0.3733 | 0.36 Cr | 6.24 Cr | 5.01 Cr | -0.90 Cr | -0.85 | 5.74 Cr | -0.0097 |
| 2022-03-31 | 80.00 Cr | 17.17 Cr | 33.65 Cr | 0.4206 | 0.12 Cr | 4.64 Cr | 9.86 Cr | 2.36 Cr | 2.24 | 10.67 Cr | 0.0295 |
| 2021-03-31 | 61.87 Cr | 15.33 Cr | 46.54 Cr | 0.7523 | 0.08 Cr | 3.62 Cr | 19.97 Cr | -4.84 Cr | -4.59 | 0.86 Cr | -0.0783 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.39 Cr | 128.76 Cr | 115.87 Cr | 9.4935 Cr | 70.66 Cr | 67.27 Cr | 12.96 Cr | 40.28 Cr | 0.00 Cr | 0.00 Cr | 26.99 Cr | 87.9750 Cr |
| 2024-03-31 | 22.79 Cr | 140.90 Cr | 105.76 Cr | 32.1636 Cr | 67.58 Cr | 44.78 Cr | 15.50 Cr | 30.72 Cr | 0.00 Cr | 0.00 Cr | 25.26 Cr | 40.4043 Cr |
| 2023-03-31 | 4.38 Cr | 115.90 Cr | 108.02 Cr | 5.5758 Cr | 73.62 Cr | 69.24 Cr | 12.49 Cr | 30.84 Cr | 14.41 Cr | 0.00 Cr | 17.95 Cr | 52.6938 Cr |
| 2022-03-31 | 2.87 Cr | 110.24 Cr | 102.30 Cr | 6.1098 Cr | 91.96 Cr | 89.15 Cr | 11.97 Cr | 26.10 Cr | 11.69 Cr | 0.00 Cr | 17.78 Cr | 60.2929 Cr |
| 2021-03-31 | 18.56 Cr | 114.49 Cr | 109.28 Cr | 3.4034 Cr | 78.95 Cr | 60.39 Cr | 11.00 Cr | 35.80 Cr | 9.59 Cr | 0.00 Cr | 17.33 Cr | 41.9202 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.7463 Cr | -14.7685 Cr | -5.3981 Cr | -12.5819 Cr | -19.4058 Cr | 3.3891 Cr | -13.3282 Cr | -14.6991 Cr | -5.3980 Cr | 0.0000 Cr | -0.6883 Cr |
| 2024-03-31 | -2.2673 Cr | -0.4536 Cr | 19.8333 Cr | -3.3807 Cr | 18.4158 Cr | 22.7949 Cr | -1.1134 Cr | -1.5271 Cr | -6.0452 Cr | 0.0000 Cr | -3.0064 Cr |
| 2023-03-31 | 9.8579 Cr | -7.2181 Cr | -1.1350 Cr | 3.6755 Cr | 1.5048 Cr | 4.3791 Cr | -6.1825 Cr | 4.2629 Cr | 3.6870 Cr | 0.0000 Cr | -0.5188 Cr |
| 2022-03-31 | -0.5017 Cr | -1.9091 Cr | -13.2744 Cr | -3.3509 Cr | -15.6852 Cr | 2.8743 Cr | -2.8492 Cr | 9.3245 Cr | -6.7546 Cr | 0.0000 Cr | -0.9713 Cr |
| 2021-03-31 | 7.4277 Cr | -1.4395 Cr | 6.2039 Cr | 6.3855 Cr | 12.1922 Cr | 18.5595 Cr | -1.0422 Cr | -0.4163 Cr | 12.5259 Cr | 0.0000 Cr | 1.8269 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 28.61 Cr | 6.97 Cr | 21.64 Cr | 0.7565 | -5.84 Cr | 1.99 Cr | 1.92 | 5.29 Cr | 0.0695 |
| 2025-03-31 | 32.05 Cr | 5.59 Cr | 26.46 Cr | 0.8257 | 7.13 Cr | -15.54 Cr | -13.68 | -10.09 Cr | -0.4848 |
| 2024-12-31 | 31.13 Cr | 5.58 Cr | 25.55 Cr | 0.8207 | -1.92 Cr | -2.89 Cr | -2.40 | -0.95 Cr | -0.0929 |
| 2024-09-30 | 30.41 Cr | 5.52 Cr | 11.05 Cr | 0.3634 | 3.55 Cr | 3.42 Cr | 3.10 | 6.17 Cr | 0.1123 |
| 2024-06-30 | 27.47 Cr | 16.12 Cr | 11.36 Cr | 0.4133 | 0.45 Cr | 0.32 Cr | 0.26 | 1.03 Cr | 0.0115 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 3.39 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -12.89 Cr |
| 2025-03-31 | 3.39 Cr | 0.00 Cr | 3.39 Cr | 19.30 Cr | 12.96 Cr | 40.77 Cr | 40.28 Cr | 128.76 Cr | 115.87 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 7.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -39.39 Cr |
| 2024-09-30 | 7.49 Cr | 0.00 Cr | 7.49 Cr | 19.19 Cr | 13.78 Cr | 49.20 Cr | 33.47 Cr | 138.67 Cr | 99.27 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 22.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -35.13 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.99 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -14.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -2.89 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 3.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2006-04-28 | April 28, 06 | 551:1000 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹741.80 | ₹88,825,874,435.00 | ₹95,115.00 |
Key Executives
Gender: male
Year Born: 1977
Gender: Not Specified
Year Born: 1954
Gender: male
Year Born: 1969
Gender: male
Year Born:
FAQs about Kerala Ayurveda Limited
The CEO is Vivek Sunder.
The current price is ₹462.15.
The range is ₹305-625.
The market capitalization is ₹556.08 crores.
The P/E ratio is -36.76.
The company operates in the Healthcare sector.
Overview of Kerala Ayurveda Limited (ISIN: INE817B01025) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹556.08 crores and an average daily volume of 27,372 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.